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Abstract For murine polyomavirus (Py), previous studies sug-
gest the cellular target is a terminal K2,3-linked sialic acid.
Here, we investigate the binding and uptake of mouse polyoma-
virus-like particles (PyVLP) derived from bacterially expressed
VP1. We ¢nd that in ¢broblast 3T6 cells, binding of PyVLP
was substantially reduced by sialidase treatment, but only mod-
erately a¡ected by protease treatment, suggesting glycolipids
such as the sialic acid-containing gangliosides mediate cell at-
tachment. We further tested the entry requirement of PyVLP
using the ganglioside-de¢cient GM95 murine cell line, and ¢nd
PyVLP binding and entry were reduced in these cells. Finally,
we ¢nd that addition of gangliosides GM1, GD1a, and GT1b to
GM95 cells restored cellular PyVLP binding and uptake. Taken
together, results indicate that gangliosides function in PyVLP
cell attachment and endocytosis.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
To replicate in a host cell, animal viruses have evolved
multiple strategies for binding to the cell surface, penetrating
cellular membranes and uncoating their encapsulated genome.
For the small, non-enveloped murine polyomavirus (Py),
binding is receptor mediated, and following endocytosis, leads
to the nuclear delivery of a replication-competent genome.
Binding of Py requires a direct interaction of the host plasma
membrane receptor with surface-exposed domains of the 45
nm viral capsid [1]. The viral capsid shell is constructed of the
major structural protein, VP1, where 72 pentons are organized
into a T=7 icosahedral structure that encases the double-
stranded DNA genome and cellular histones [2]. VP1 binds
the minor structural proteins VP2 and VP3 [3], which are
masked within the capsid shell. The structural integrity of
the capsid requires only VP1, as Escherichia coli-derived
VP1 can be assembled in vitro into virus-like particles
(PyVLP) [4].
Evidence by Caruso et al. implicates K4,L1 integrin as a
post-attachment receptor for Py [5], whereas biochemical
and structural evidence suggests the target for Py cell attach-
ment is a terminal K2,3-linked N-acetyl neuraminic acid, com-
monly known as sialic acid [6^8]. Sialic acid modi¢cations are
found on a variety of cell surface glycoproteins, and on a
subfamily of glycosphingolipids called gangliosides. Ganglio-
sides are known to be the cellular target for several toxins,
including cholera toxin (GM1), tetanus toxin (GD1b, GT1b) and
botulinum toxin (GT1b, GQ1b). These glycosphingolipids are
composed of ceramide linked by a glycosidic bond to an ol-
igosaccharide chain of hexoses, including glucose, galactose
and N-acetylgalactosamine, and K2,3- or K2,8-linked sialic
acid units. Terminal K2,3-linked sialic acid is found on one
of two types of branches. The ¢rst branch type, found in GM3,
GM2, and GM1, contains linkages to ceramide extending as:
ceramide-glucose-L1,4-galactose-K2,3 sialic acid. The second
occurs in gangliosides such as GD1a and GT1b on a longer
galactose branch, where the linkages are: ceramide-glucose-
L1,4-galactose-L1,4-N-acetylgalactosamine-L1,3-galactose-K2,3
sialic acid.
Here we investigate the binding and uptake of mouse Py
using in vitro assembled virus-like particles as a non-infectious
source of Py. Protease-treated cells remain competent for
binding PyVLP, whereas cholera toxin and antibodies to
GM1 function as competitive inhibitors for Py binding, sug-
gesting that glycolipids including ganglioside GM1 may func-
tion at the level of cell attachment. We investigate the receptor
usage and internalization of PyVLP further using the ceram-
ide-glucosyl-transferase-de¢cient murine cells, GM95, which
lack gangliosides. In the GM95 cells, we ¢nd that cell associ-
ation and internalization of PyVLP and cholera toxin is re-
duced. Finally, upon addition of gangliosides to the GM95
cells, binding and endocytosis of PyVLP is restored in the
ganglioside-supplemented cells.
2. Materials and methods
2.1. Cell culture
3T6 Swiss albino ¢broblasts, and the mouse B16 melanoma mutant
cell lines MEB4 and GM95 were grown in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) (Gibco) with 10% fetal calf serum (FCS)
(LabForce AG) and 4 mM glutamax (Gibco) at 37‡C in 5% CO2.
For biochemical assays, 3T6, MEB4 and GM95 cells (80% con£uent)
were removed with 0.8% ethylenediamine tetraacetic acid^phosphate-
bu¡ered saline (EDTA^PBS 3/3). The GM95 and MEB4 cells were a
kind gift from H. Sprong [9].
2.2. Antibodies and reagents
Puri¢cation of wild-type VP1 and VLP assembly was as described
[10]. Fluorescent VLP capsids were prepared by covalent coupling of
dye according to the manufacturer’s directions. Speci¢cally, Alexa-
Fluor-594- or £uorescein isothiocyanate (FITC)-succinimidyl ester de-
rivatives (Molecular Probes) were coupled at a 5-fold molar excess of
dye to VP1 protein, and unbound dye was removed by chromatog-
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raphy with a Nap-5 column (Pharmacia). For live cell microscopy,
0.1^0.5 Wg PyVLP was added per 1U106 cells on a 18 mm coverslip.
Unlabeled cholerae toxin L subunit (Sigma) was used at the indicated
concentrations for biochemical competition experiments. Cholera tox-
in L subunit labeled with FITC or AlexaFluor-488 (Sigma) (0.1^1 Wg/
ml), and transferrin-FITC (5 Wg/ml) (Molecular Probes) were used for
microscopy. Polyclonal antibodies to GM1 (US Biologicals) were used
for competition experiments at a ¢nal dilution of 1:50, and for im-
muno£uorescence (IF) at 1:200. Highly puri¢ed monoclonal antibod-
ies to GT1b and GD1a (US Biologicals) were used for IF at a dilution
of 1:100 (10 Wg/ml), and did not block uptake of PyVLP under any
conditions.
2.3. Enzyme-treated cell preparation
For enzyme-treated cells, neuraminidase (0.1 unit V. cholerae/106
cells) (Sigma) pretreatment was at 30‡C for 1 h at pH 6.0 to activate
the enzyme, cells were washed and pH adjusted to 7.0 for binding.
Trypsin (0.1%) (Gibco) pretreatment was at 37‡C for 30 min, followed
by serum inactivation. Proteinase K pretreatment (5 mg/ml) (Boehr-
inger Mannheim) was for 1 h at 30‡C, followed by washing. Cells
were counted before processing.
2.4. Glycolipid supplementation assay
Supplementation of glycolipids was as described [11] with ganglio-
sides (Avanti, US Biologicals) and lactosylceramide-C5-bodipy (5 WM)
(Molecular Probes). Brie£y, gangliosides (20 Wg/ml) were incubated as
micelles for 12 h at 37‡C in serum-free media. Cells were viable for
18 h. After overnight incubation, cells were shifted to 4‡C, washed in
DMEM containing 25% serum and incubated brie£y with trypsin.
Cells were washed with FCS-containing media, and with binding bu¡-
er before the addition of ligands. For IF of supplemented ganglio-
sides, cells were ¢xed with 4% ¢nal formaldehyde, and antigen was
detected with speci¢c antibodies as indicated (antibodies and reagents)
in absence of permeabilization.
2.5. 125I-PyVLP-biotin-SS attachment and internalization assay
Generation of 125I-PyVLP-biotin-SS was as described [12]. For
PyVLP, a speci¢c activity of 3.4U106 counts per minute (cpm) per
Wg was determined. For binding and internalization assays 0.3 Wg 125I-
PyVLP-biotin-SS per 0.5U106 cells were used. Binding and internal-
ization assay were as described [12]. Radioactivity from cell-associated
(binding) or immunoprecipitated biotin-tagged virus (internalization)
is expressed as percentage of total input activity, after background
subtraction (background was approximately 5%). For antibody and
cholera toxin blocking experiments, cells were pretreated for 1 h at
4‡C with competitor, and then processed, where the competitor re-
mained in the binding mix.
2.6. Microscopy
Confocal images were acquired with an inverted Zeiss LSM 510
meta (100U objective, N.A. 1.4, pinhole setting at 1 airy unit). Epi-
£uorescence microscopy was performed using a Zeiss Axiovert micro-
scope with a 100U/1.40 N.A. plan-Apochromat lens, and images were
collected with a CCD camera (Hamamatsu Inc.). Quantitation of
confocal images in Fig. 1A was done using Zeiss LSM 510 analysis
tools (Carl Zeiss) and Excel (Microsoft). The average £uorescence
intensity per squared micron was calculated from the selected region
of interest (ROI) for the two channels (T-1, red; T-2, green) from a
12-bit image, and graphed in arbitrary units (1^4095). Images were
exported as 8-bit TIFF’s from Openlab LIFF (Improvision) and Zeiss
¢le formats (.lsm), and were processed in Photoshop 6.0 (Adobe).
3. Results
Polyomavirus-like particles (PyVLP) were generated from
bacterially derived VP1, and £uorescently labeled with Alexa-
Fluor-594- or FITC-succinimidyl ester (Py594, PyFITC).
Throughout this work, cell association (or binding) was ana-
lyzed in cells shifted to 4‡C to block endocytosis, and uptake
(or endocytosis) was evaluated following release from the tem-
perature block with a shift to 37‡C. During initial studies, we
monitored the cell association of PyVLP and cholera toxin L,
which is a well-studied ligand for caveolae-mediated endocy-
tosis [13,14] and perhaps other uptake pathways [14]. Alexa-
Fluor-488-labeled cholera toxin L (Ctx488) and Py594 were
simultaneously added to 3T6 cells for 30 min at 4‡C. Follow-
ing ¢xation, analysis using confocal microscopy showed that
for Ctx488 uptake was extremely heterogeneous, and that cell-
Fig. 1. Cell association of PyVLP is lipid mediated. A: Images:
Cholera toxin L-AlexaFluor-488 (Ctx488) and PyVLP-AlexaFluor-
594 (Py594) were simultaneously visualized in 3T6 cells with confo-
cal microscopy. Grayscale (left, Ctx488; middle, Py594), and merged
(right) images are presented. Graph: Quantitation of average £uo-
rescence intensity per square micron for ROI (n=11) of the two
channels (T-1, red, T-2, green) from 12-bit image is graphed in arbi-
trary units (1^4095). B: Cell-associated cpm of 125I-Py-biotin (1 Wg
virus in 1 ml) in the presence of competitor Ctx is graphed as per-
cent untreated control. Error bars are average of three independent
experiments. C: Cell-associated cpm of 125I-Py-biotin in protease
(trypsin, proteinase K), sialidase (neuraminidase), or anti-GM1 pre-
treated cells is graphed as above.
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associated Py594 seems to be reduced in cells where Ctx488
was robustly bound (Fig. 1A, top panel). We measured the
average £uorescence intensity units per square micron for
both probes in randomly selected 3T6 cells (n=11) and no-
ticed a trend suggesting that binding of PyVLP is reduced
where cholera toxin L cell association was most e⁄cient
(Fig. 1A, bottom panel). We further observed the reciprocal
reduction in cell-associated Ctx in the presence of excess
PyVLP (data not shown).
To quantify whether there was, indeed, a dose-dependent
inhibition of PyVLP in the presence of Ctx, we generated
radio-iodinated PyVLP for use in a biochemical uptake assay
[12]. The iodinated PyVLP was additionally biotin labeled
with a compound that contained a disul¢de bond in the
spacer region, sulfo-NHS-SS-biotin, to generate 125I-Py-bio-
tin. Cell association can thus be distinguished from internal-
ization upon treatment with a membrane-impermeable reduc-
ing agent where only intracellular virus maintains a biotin tag.
The intracellular virus can then be speci¢cally immunopreci-
pitated with an anti-biotin antibody. 3T6 cells were incubated
with increasing concentrations of Ctx for 30 min at 4‡C and
125I-Py-biotin was added to the cells in the presence of com-
petitor Ctx for an additional 1 h at 4‡C to allow for virus^cell
attachment. Total cell-associated radioactivity expressed as
cpm was compared between samples relative to the untreated
control (Fig. 1B). Results indicate that in the presence of
excess cholera toxin, cell association of PyVLP is reduced
(maximal reduction= 31.1S 7.9%).
Cholera toxin L uses ganglioside GM1 [15], a glycolipid that
contains one K2,3-linked sialic acid residue, as a speci¢c re-
ceptor. We speculated that the observed reductions in cell-
associated PyVLP in the presence of cholera toxin (Fig. 1A
and B) was due to a direct competition at the cell surface for
GM1. This suggested the possibility that a glycolipid functions
as a cellular receptor for PyVLP.
To test this hypothesis, we ¢rst asked if PyVLP cell associ-
ation was altered when plasma membrane proteins are re-
moved with proteases. Cell-associated radioactivity (cell-asso-
ciated cpm) following binding at 4‡C for 1 h of 125I-Py-biotin
in trypsin (cell-associated cpm=83.2 S 18.3%) or proteinase K
(cell-associated cpm=75.6S 17.7%) pretreated cells was par-
tially reduced compared to that of untreated cells (cell-asso-
ciated cpm=100%). We next veri¢ed that cell attachment was,
indeed, dependent upon sialic acid. When 3T6 cells were
treated with the sialidase, called neuraminidase, cell-associated
cpm of 125I-Py-biotin was extensively reduced (cell-associated
cpm=37.4S 15.2%) (Fig. 1C). Finally, we ¢nd that binding of
125I-Py-biotin was also reduced in the presence of a polyclonal
antibody to GM1 (cell-associated cpm=51S6.8%) (Fig. 1C).
Using confocal microscopy, anti-GM1 antibody competition
was also observed to inhibit Py594 binding to 3T6 cells
(data not shown). Taken together, these data suggest that
the bulk of cell attachment of PyVLP in 3T6 cells is lipid
mediated, and that the ganglioside GM1 is a candidate target.
To test the requirement for gangliosides in the binding and
endocytosis of PyVLP, we obtained a murine B16 melanoma
cell line mutagenized subclone, GM95, which lacks the ceram-
ide-glucosyl-transferase gene and has no glycolipids [9,16,17].
We visualized the cell-associated Py594 and Ctx488 in 3T6
and GM95 cells with epi£uorescence microscopy. We ob-
served no cell-associated Ctx488 (Fig. 2A, panels C, D) in
GM95 cells, and that cell-associated PyVLP (Fig. 2A, panels
E, F) was reduced in the GM95 cells relative to the 3T6 cells.
A substrate for clathrin-mediated uptake, AlexaFluor-488-
transferrin (Tfn488), was internalized with similar e⁄ciency
in 3T6 and GM95 cells (Fig. 2A, panels A, B).
Using the biochemical uptake assay, we quanti¢ed the levels
of cell-associated 125I-Py-biotin following binding at 4‡C for
1 h for three murine cell lines: 3T6, GM95 and MEB4 cells.
MEB4 cells are a subclone of B16 melanoma cells containing
a functional ceramide-glucosyl-transferase gene and, unlike
Fig. 2. Binding and endocytosis of PyVLP is reduced in the glycoli-
pid-de¢cient cells, GM95. A: Epi£uorescent micrographs of trans-
ferrin-AlexaFluor-488 (Tfn488), cholera toxin L-AlexaFluor-488
(Ctx488), and PyVLP-AlexaFluor-594 (Py594) in 3T6 (A, C, E, re-
spectively) and in GM95 (B, D, F, respectively) cells. B: Cell-associ-
ated cpm of 125I-Py-biotin in 3T6, GM95 and MEB4 cells is
graphed as a percent of 3T6 binding (100%). C: Timecourse of
125I-Py-biotin uptake in 3T6 (F), MEB4 (8) and GM95 (b) cells,
where the internalized fraction of virus is graphed as a percent of
total virus input following background subtraction.
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GM95 cells, the MEB4 cells contain glycolipids, principally
GM3 and glucosylceramide [16]. We ¢nd that in GM95 cells,
cell-associated cpm is reduced to 40.9 S 3.4%, when compared
to that of 3T6 cells (100%), while for the MEB4 cells binding
was reduced to 65.8S 7.2% relative to 3T6 cells (Fig. 2B).
Confocal microscopy of MEB4 and GM95 cells con¢rms
that binding and uptake of PyVLP is enhanced in the
MEB4 cells in comparison to GM95 cells (data not shown).
To measure endocytosis, 125I-Py-biotin was bound at 4‡C
for 1 h, and samples were then shifted to 37‡C to allow for
internalization in the presence of excess unbound virus. At
varying time points, samples were removed, endocytosis was
inhibited with a temperature block, and cells were treated with
Tris-(2-carboxyethyl) posphine (TCEP), a membrane-imper-
meable reducing agent, to speci¢cally cleave the biotin residue
from the extracellular virus particles. Cells were lysed and the
internalized virus was immunoprecipitated with an anti-biotin
antibody. Uptake of virus in the 3T6 cells was rapid and
without an observable lag phase in the ¢rst 30 min (Fig.
2C), where 20S 2.2% of total radioactivity was internalized
at 150 min. For the MEB4 cells, uptake was less e⁄cient
where 8S 0.8% of total radioactivity was internalized at 150
min (Fig. 2C). In contrast to 3T6 and MEB4 cells, virus in-
ternalization was remarkably ine⁄cient in GM95 cells
(1.7 S 1.5% total cpm at 150 min) (Fig. 2C). Taken together,
£uorescence microscopy and biochemical data provide evi-
dence that gangliosides play a functional role in the endocy-
tosis of PyVLP. As cell association was also reduced in GM95
cells, gangliosides may be cellular receptors that stimulate
uptake of PyVLP.
To directly test a panel of gangliosides for their ability to
rescue binding and stimulate endocytosis of PyVLP, we sup-
plemented GM95 cells with puri¢ed, exogenous gangliosides.
Exogenous lipids are incorporated into live cells through in-
cubation with lipid micelles, where lipids in the plasma mem-
brane spontaneously exchange with the exogenous pool [11].
However, because we cannot determine the moles of individ-
ual gangliosides that properly insert into the plasma mem-
brane during the supplementation assay, comparisons can
only be made relative to the untreated control.
We supplemented the GM95 cells with GD1a and GT1b,
which contain a long branch terminal K2,3-linked sialic acid
galactose, and GM1 with a short terminal K2,3-linked sialic
acid galactose branch. The insertion of lipids into the plasma
membrane of GM95 cells was monitored using antigen-specif-
ic antibodies against each ganglioside (data not shown). To
test endocytosis using live cell confocal microscopy, we fol-
lowed the internalization of FITC-labeled PyVLP (Py-FITC)
in ganglioside-supplemented GM95 cells following binding at
4‡C for 1 h, and a temperature shift for 1 h to 37‡C. We
speci¢cally visualized the intracellular fraction of Py-FITC
using an acidi¢ed medium, thereby quenching the extracellu-
lar FITC £uorescence signal. We ¢nd GM1, GD1a and GT1b
were each su⁄cient to rescue uptake (Fig. 3A). The uptake of
FITC-cholera toxin L was speci¢cally stimulated only in GM1-
supplemented cells (Fig. 3A). We determined the timecourse
for uptake of 125I-Py-biotin in GM95 cells following ganglio-
side addition. Results indicated that in ganglioside-supple-
mented GM95 cells, internalization is e⁄ciently stimulated
relative to the untreated control (Fig. 3B). Lactosylcera-
mide-supplemented cells, lacking sialic acid, did not stimulate
internalization of PyVLP (Fig. 3B). Ganglioside-dependent
Fig. 3. Addition of gangliosides restores PyVLP cell attachment and internalization in GM95 cells. A: Confocal micrographs in ganglioside-
supplemented GM95 cells of cholera toxin L-FITC (Ctx-FITC) or PyVLP-FITC (Py-FITC) where GM1 (A, B), GD1a (C, D), GT1b, (E, F) or
no ganglioside (G, H) was added. Micrographs are of live cells in acidic media to quench extracellular FITC signal. B: Timecourse of 125I-Py-
biotin uptake in GM95 cells where cells were supplemented with GM1 (b), GD1a (F), GT1b (R), LacCer (8), or untreated (*). Internalized frac-
tion of virus is graphed as a percent of total virus input. C: Cell-associated cpm of 125I-Py-biotin in GM95 cells supplemented with GM1,
GD1a, or GT1b where total bound fraction at t=0 (bound, no internalization) and t=2 h at 37‡C (bound, 2 h internalization) is normalized to
untreated control.
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cell association in GM95 cells of 125I-Py-biotin was deter-
mined, and GM1-, GD1a-, and GT1b-supplemented cells all
showed increased binding activity when compared to un-
treated control samples (Fig. 3C). The cell-associated cpm
accumulated over time during endocytosis for 2 h in ganglio-
side-supplemented cells, but only poorly in the untreated con-
trol cells. Taken together, these data suggest that multiple
gangliosides function in cell attachment as receptors and
that these glycolipids are required for endocytosis of PyVLP.
4. Discussion
In summary, the major conclusion of this work is that gly-
colipids function in cell attachment and endocytosis of
PyVLP. We showed that glycolipids are preferentially targeted
over glycoproteins for cell attachment of PyVLP in 3T6 cells
(Fig. 1C), and that supplementation of gangliosides contain-
ing terminal K2,3-linked sialic acid-galactose to a cell line
devoid of glycolipids was su⁄cient to restore binding and
e⁄cient uptake (Fig. 3). PyVLP can therefore engage multiple
gangliosides for binding and internalization. The availability
of gangliosides and the presence of alternative glycoprotein
targets are likely major determinants for cellular tropism.
The GM3-positive MEB4 cells are an example where only
one ganglioside family member is present, and PyVLP endo-
cytosis occurs.
Recent evidence provided by Tsai et al. [18] suggests that
gangliosides GD1a and GT1b are required for Py infection.
Here, we show that GM1- and GM3-dependent mechanisms
for internalization exist for PyVLP in murine cell lines,
although uptake may not lead to productive infection [19].
Interestingly, the virus-like particles that bound to GM95 cells
in a ganglioside-independent manner lacked endocytic poten-
tial (Fig. 2), implicating ganglioside function in a post-attach-
ment process, perhaps via signal transduction. One attractive
possibility is that PyVLP endocytosis involves ligand-induced,
ganglioside-mediated signal transduction from the outer plas-
ma membrane lea£et to the cytosolic endocytic machinery. It
will be important to determine if signaling pathways engaged
by PyVLP through various gangliosides di¡er, and identify
determinants for pathogenicity.
Finally, pathogens including virus, bacteria, and their tox-
ins are part of a growing class of ligands that make use of
lipids for binding and endocytosis [20]. Recent evidence for
cholesterol-dependent, lipid raft-mediated endocytic pathways
indicates that some pathogens have evolved to exploit lipid
rafts during infection. Further study of the mechanisms by
which pathogens use these organized lipid membrane domains
are likely to yield insight into the biological role of lipid rafts
in endocytosis and membrane tra⁄cking.
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